Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayJul 29, 2026 9:45 am

VERAXA Biotech AG (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform

The company has appointed antibody therapeutics specialist Dr. Christoph Erkel as Chief Scientific Officer. The leadership change comes as the company advances its proprietary BiTAC(R) technology platform toward clinical development. VERAXA is building a diversified oncology pipeline that includes conditionally active T-cell engagers, bispecific ADCs and other engineered antibody therapeutics. Recent regulatory feedback from Germany's Paul-Ehrlich-Institute has provided additional clarity for development of the company's lead BiTAC(R)-TCE program. Investors are watching companies developing next-generation immunotherapies that seek to improve efficacy while reducing treatment-related toxicity. VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has appointed antibody therapeutics…

Continue Reading

WednesdayJul 29, 2026 9:00 am

American Fusion(TM) Inc. (AMFN) Expands Commercial Leadership as Texatron(TM) Development Advances Through Testing, Regulatory and Patent Milestones

The company has appointed Alec Rossa as Chief Revenue Officer to lead commercialization, strategic partnerships, and deployment of the company's planned Power-as-a-Service (“PaaS”) business model. Management says early commercial opportunities include AI data centers, industrial facilities, defense applications and other energy-intensive infrastructure. The company is pursuing a strategy that combines technology development, intellectual property protection and recurring revenue through long-term Power-as-a-Service agreements. American Fusion(TM) recently highlighted progress on its Texas Tech University testing program, following regulatory authorization covering all twelve Texatron(TM) Fusion Engine(TM) research systems.  American Fusion(TM) has also expanded its intellectual property portfolio to 76 U.S. patent applications, moving…

Continue Reading

TuesdayJul 28, 2026 11:15 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Clinical and Regulatory Milestones

Regentis is advancing GelrinC through a pivotal stage of development, with key catalysts including U.S. clinical study enrollment, European commercialization activities, and continued manufacturing optimization. Strategic interest in cartilage regeneration technologies was highlighted by Smith+Nephew’s acquisition of CartiHeal for up to $330 million, underscoring the potential value of innovative orthopedic solutions designed to address unmet needs in cartilage repair. GelrinC is an off-the-shelf, cell-free, one-step hydrogel-based implant designed to simplify cartilage repair through a procedure that supports and mimics the body's natural regenerative processes. Cartilage Regeneration Gains Strategic Validation The orthopedic industry is increasingly focused on technologies that can address…

Continue Reading

TuesdayJul 28, 2026 10:30 am

Why GPS-Free Navigation Is Becoming Essential for Modern Military Drones

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. Drones play a crucial role in modern military operations, but it’s becoming increasingly more important for these drones to operate without relying on GPS, due to the prevalence of jamming and other issues. Growing demand for GPS-independent drone navigation has prompted companies such as Robotto to pivot their technologies toward defense applications. Another company operating in this expanding market is SPARC AI, which develops GPS-free target acquisition and autonomous navigation software for drones and other edge devices. Few technologies have reshaped modern warfare as…

Continue Reading

TuesdayJul 28, 2026 9:45 am

Numa Numa Resources Inc. Supports Resource Development as Bougainville Charts Future

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Geographically part of the Solomon Islands archipelago, Bougainville has been politically linked to Papua New Guinea since the colonial era. One of the central questions surrounding Bougainville’s independence is economic viability. Numa Numa is working with landowner groups and local stakeholders to advance mining opportunities while respecting Bougainville’s legal framework and customary ownership systems. For Bougainville, the path to independence is about more than politics. It is also about economics. As the autonomous Pacific region continues discussions regarding its future political status, the development of its vast…

Continue Reading

TuesdayJul 28, 2026 9:00 am

Earth Science Tech Inc. (ETST) Capitalizing on Diversified, Synergistic Operations to Deliver Dilution-Free and Cash-Flow Driven Growth

Earth Science Tech, through its specialized subsidiaries, has created a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine, clinical support, and fulfilment RxCompoundStore and Mister Meds are licensed compounding pharmacies, which produce custom medications that are supplied wholesale to independent clinics and directly to consumers through ETST’s other subsidiary, Peaks Curative LLC The subsidiaries create a dual-market operation that reduces reliance on one market segment and continues to contribute to Earth Science Tech’s cash-flow-driven and dilution-free growth In fiscal year 2026, Earth Science Tech reduced its total liabilities and increased its total assets, resulting in a net increase…

Continue Reading

MondayJul 27, 2026 10:30 am

Wrap Technologies Inc. (NASDAQ: WRAP) Brings Remote Restraint Innovation and Emerging Detection Technology to Modern Public Safety

Pressure on agencies to adopt response-to-resistance alternatives has intensified, widening demand for tools that can control situations without injury or pain rather than provoke confrontations. Wrap has built its business around a Non-Lethal Response(TM) platform that converges remote restraint, training, and evidence management, spanning the BolaWrap(R) 150, Wrap Reality(TM), Wrap Vision(TM), Wrap Tactics(TM), and counter-drone solutions. With the July 2026 launch of WrapShield(TM) and an exclusive U.S. and NATO license to Frenel Imaging’s TPiCore(R) thermal-polarimetric sensing, Wrap is adding an AI-enabled detection layer, beginning with counter-UAS. A Widening Market for Response-to-Resistance Technology High-profile use-of-force incidents have driven costly litigation, strained…

Continue Reading

MondayJul 27, 2026 9:45 am

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Reports Two Key Announcements, Advancing REE Portfolio Across Brazil and Canada

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. China accounts for around 60% of global mined production of magnet rare earths, while demand for the REEs that go into electric motors, wind turbines and defense systems has doubled since 2015. Canamera Energy Metals reported assay results from its Turvolândia Ionic Clay Rare Earth Project in Minas Gerais, Brazil, expanding the project from four to seven drill-confirmed rare earth target areas. The company also announced an option agreement with Nemo Resources Inc. to acquire 100% interest in the Rare Earth Ridge rare…

Continue Reading

MondayJul 27, 2026 9:00 am

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Combining Three Emerging Frontiers in Cancer Drug Development

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. As precision oncology becomes increasingly dependent on biomarker-driven therapies, smarter clinical trial design, and advanced drug delivery technologies, companies capable of integrating may be better positioned to address some of oncology's most persistent development challenges. Onco-Innovations pairs a PNKP inhibitor, a DDR target distinct from PARP, with a nanoparticle delivery system in its lead candidate ONC010, and adds AI through its Inka Health subsidiary and the SynoGraph causal AI platform Onco-Innovations is advancing ONC010 through IND-enabling, manufacturing, and regulatory work, while using AI-enabled tools intended to support…

Continue Reading

FridayJul 24, 2026 11:15 am

Greenland Mines Ltd. (NASDAQ: GRML) Advances World-Class Palladium Deposit with Major Resource Upgrade

The combination of a structurally concentrated supply base, rising geopolitical risk from the dominant Russian supplier, and persistent demand from the automotive sector creates a clear rationale for Western nations to secure alternative sources of palladium. The latest news from Greenland Mines confirms that its Skaergaard project just became more valuable. The 2026 field season is already underway at Skaergaard, with drilling, bulk sampling for metallurgical test work, geotechnical measurements, engineering studies and environmental baseline all in progress. Palladium is one of the most strategically important metals on earth, and the supply chain that delivers it to Western manufacturers has never been…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000